New study shows that digital assistance improves physician’s accuracy to predict who will develop complication to cirrhosis and die from alcohol-related liver disease.
Five abstracts from the GALAXY project was presented on 27-29 August at the Digital International Liver Congress 2020
In May 2020 an important milestone in the Rifaximin study was reached, since the last of 136 participants was included.
The GALAXY partners met in Copenhagen for Steering Committee Meeting
GALAXY had two oral presentations at the Liver Meeting 2019 - one was selected as part of Best of Liver Meeting 2019
GALAXY hosted meeting at AASLD in Boston